M. Lindsay Grayson

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Evelina Tacconelli, Elena Carrara, Alessia Savoldi et al. · The Lancet Infectious Diseases · 2017 · 6.1K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Treatment Outcomes for Serious Infections Caused by Methicillin‐Resistant<i>Staphylococcus aureus</i>with Reduced Vancomycin Susceptibility

Benjamin P. Howden, Peter Ward, Patrick G. P. Charles et al. · Clinical Infectious Diseases · 2004 · 485 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin‐Intermediate<i>Staphylococcus aureus</i>

Patrick G. P. Charles, Peter Ward, Paul D. R. Johnson et al. · Clinical Infectious Diseases · 2004 · 384 citations

Life Sciences, Infectious Diseases, Microbiology +15

Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin‐resistant Staphylococcus aureus (MRSA) infection

Paul D. R. Johnson, Rhea Martin, Laurelle J Burrell et al. · The Medical Journal of Australia · 2005 · 259 citations

Public Health, Infectious Disease Control, Infectious Diseases +17

Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci

Benjamin P. Howden, Kathryn E. Holt, Margaret M. C. Lam et al. · mBio · 2013 · 238 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17